Moreover, individuals with NSCLC were found to have demethylation at eight CpG sites in the foxp3 promoter, with methylation levels showing a negative correlation with the proportion of CD4+ CD25+ Foxp3+ T cells. Here, FOXP3 is linked to non-small cell lung carcinoma.